Florian Rader, MD
Enriched profileAssociate Director, Noninvasive Laboratory; Medical Director, Hypertension Center of Excellence; Co-Director, Hypertrophic Cardiomyopathy Clinic, Smidt Heart Institute; Associate Professor, Cedars-Sinai and UCLA · Cedars-Sinai Heart Institute
Florian Rader is Associate Director, Noninvasive Laboratory; Medical Director, Hypertension Center of Excellence; Co-Director, Hypertrophic Cardiomyopathy Clinic, Smidt Heart Institute; Associate Professor, Cedars-Sinai and UCLA at Cedars-Sinai Heart Institute. OpenAlex indexes 222 publications with 8,693 citations (h-index 37); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Florian Rader, MD, is Associate Director, Noninvasive Laboratory at Cedars-Sinai Heart Institute (Smidt Heart Institute), Los Angeles, CA. The public record shows 222 publications with 8,693 citations (h-index 37), centered on Cardiovascular Function and Risk Factors, Cardiac Valve Diseases and Treatments, Cardiomyopathy and Myosin Studies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 10 companies, 1 NIH-funded awards (2018–2018).
- Most recent indexed publication: 2025 · Circulation
- Top research focus: Cardiovascular Function and Risk Factors
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 87.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
- Effects of Hookah (Waterpipe) Smoking on Blood Vessel Function
Sponsor: Cedars-Sinai Medical Center
- E-Cigarette Aerosol, Conventional Cigarette Smoke, and Myocardial Perfusion
Sponsor: Cedars-Sinai Medical Center
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202561 payments$34,214openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202517 payments$26,515openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202510 payments$13,285openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93.6%Angiotensin receptor blocker (ARB)21.3%Telmisartan72%Irbesartan21%Valsartan5%Losartan Potassium3%Part D<11 patientsBeta blocker15.1%Carvedilol48%Metoprolol Succinate26%Nebivolol Hcl24%Toprol Xl3%Part D<11 patientsBlood & clotting
3.9%Factor Xa inhibitor3.2%Eliquis76%Xarelto24%Part D<11 patientsP2Y12 inhibitor0.7%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
2%SGLT2 inhibitor0.9%Farxiga54%Jardiance46%Part D<11 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2018–2018 per NIH RePORTER. The latest:
- Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function
Cedars-Sinai Medical Center
FY2018$217,103R21DA041596
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Pharmacist's Role in the Success of Blood Pressure Control Interventions: Evidence Isn't the Barrier….
Circulation. Cardiovascular quality and outcomes
Comment2024 - Long-Term Safety and Antihypertensive Effects of Renal Denervation: Current Insights.
Integrated blood pressure control
Review2023
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/florian-rader-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Florian-Rader
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/florian-rader-98a48246
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
acc.org/Membership/Person
- Other
cardiocaretoday.com/post/unmasking-a-hidden-driver-of-hypertension-insights-from-dr-florian-rader
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiocaretoday.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Physician Scientist Training Program
Case Western Reserve University / MetroHealth Medical Center, Cleveland
2008provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗ - MD
University of Vienna Faculty of Medicine, Austria
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗ - Board Certified
Internal Medicine, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Board Certified
Cardiovascular Disease, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Peer reviewer for multiple cardiovascular journals (Elsevier/Springer Nature platforms)
active through 2025-2026
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗ - Principal Investigator
Cedars-Sinai trial site for FDA-approved device treating treatment-resistant hypertension
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cedars-sinai.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org ↗
Media & interviews
press, podcasts and appearances- "Unmasking a Hidden Driver of Hypertension: Insights from Dr. Florian Rader"
video interview on aldosterone dysregulation in resistant hypertension, published July 2025
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cedars-sinai.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology